nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—FMO3—sweat—celiac disease	0.0434	0.0966	CbGeAlD
Vandetanib—ORM1—bile—celiac disease	0.0142	0.0316	CbGeAlD
Vandetanib—FMO3—urine—celiac disease	0.0124	0.0275	CbGeAlD
Vandetanib—ORM1—saliva—celiac disease	0.00927	0.0206	CbGeAlD
Vandetanib—TYRO3—connective tissue—celiac disease	0.00521	0.0116	CbGeAlD
Vandetanib—BLK—lymphoid tissue—celiac disease	0.0052	0.0116	CbGeAlD
Vandetanib—LYN—connective tissue—celiac disease	0.00519	0.0115	CbGeAlD
Vandetanib—BLK—blood—celiac disease	0.00489	0.0109	CbGeAlD
Vandetanib—PTK6—digestive system—celiac disease	0.00487	0.0108	CbGeAlD
Vandetanib—BMPR1B—epithelium—celiac disease	0.00485	0.0108	CbGeAlD
Vandetanib—PTK6—blood—celiac disease	0.00464	0.0103	CbGeAlD
Vandetanib—FLT3—connective tissue—celiac disease	0.00443	0.00986	CbGeAlD
Vandetanib—PDGFRB—gall bladder—celiac disease	0.0042	0.00935	CbGeAlD
Vandetanib—PLK4—lymphoid tissue—celiac disease	0.00406	0.00903	CbGeAlD
Vandetanib—RIPK2—connective tissue—celiac disease	0.004	0.00891	CbGeAlD
Vandetanib—ORM1—gall bladder—celiac disease	0.00394	0.00877	CbGeAlD
Vandetanib—ERBB3—connective tissue—celiac disease	0.00383	0.00852	CbGeAlD
Vandetanib—FLT4—epithelium—celiac disease	0.00382	0.0085	CbGeAlD
Vandetanib—PLK4—blood—celiac disease	0.00382	0.00849	CbGeAlD
Vandetanib—TYRO3—lymphoid tissue—celiac disease	0.00381	0.00848	CbGeAlD
Vandetanib—RIPK2—epithelium—celiac disease	0.0038	0.00845	CbGeAlD
Vandetanib—LYN—lymphoid tissue—celiac disease	0.00379	0.00843	CbGeAlD
Vandetanib—EPHA5—digestive system—celiac disease	0.00377	0.00837	CbGeAlD
Vandetanib—STK35—pancreas—celiac disease	0.00367	0.00817	CbGeAlD
Vandetanib—VEGFA—smooth muscle tissue—celiac disease	0.00365	0.00812	CbGeAlD
Vandetanib—ERBB3—epithelium—celiac disease	0.00364	0.00809	CbGeAlD
Vandetanib—LYN—blood—celiac disease	0.00357	0.00794	CbGeAlD
Vandetanib—RET—connective tissue—celiac disease	0.00356	0.00791	CbGeAlD
Vandetanib—AXL—connective tissue—celiac disease	0.00354	0.00787	CbGeAlD
Vandetanib—ALB—gall bladder—celiac disease	0.00346	0.00769	CbGeAlD
Vandetanib—VEGFA—pancreas—celiac disease	0.00338	0.00751	CbGeAlD
Vandetanib—RET—epithelium—celiac disease	0.00338	0.00751	CbGeAlD
Vandetanib—FYN—connective tissue—celiac disease	0.00331	0.00737	CbGeAlD
Vandetanib—ERBB3—pancreas—celiac disease	0.00324	0.00721	CbGeAlD
Vandetanib—FLT3—lymphoid tissue—celiac disease	0.00324	0.00721	CbGeAlD
Vandetanib—AXL—smooth muscle tissue—celiac disease	0.00324	0.0072	CbGeAlD
Vandetanib—TEK—connective tissue—celiac disease	0.00324	0.0072	CbGeAlD
Vandetanib—CYP3A4—urine—celiac disease	0.00323	0.00718	CbGeAlD
Vandetanib—TEK—epithelium—celiac disease	0.00307	0.00684	CbGeAlD
Vandetanib—FLT3—blood—celiac disease	0.00305	0.00678	CbGeAlD
Vandetanib—FYN—smooth muscle tissue—celiac disease	0.00303	0.00674	CbGeAlD
Vandetanib—YES1—connective tissue—celiac disease	0.00299	0.00665	CbGeAlD
Vandetanib—TEK—smooth muscle tissue—celiac disease	0.00296	0.00659	CbGeAlD
Vandetanib—MAP4K5—smooth muscle tissue—celiac disease	0.00296	0.00659	CbGeAlD
Vandetanib—FLT4—lymphoid tissue—celiac disease	0.00294	0.00655	CbGeAlD
Vandetanib—ABL2—blood—celiac disease	0.00291	0.00648	CbGeAlD
Vandetanib—RIPK2—digestive system—celiac disease	0.00289	0.00643	CbGeAlD
Vandetanib—SLK—pancreas—celiac disease	0.00288	0.00641	CbGeAlD
Vandetanib—SRC—connective tissue—celiac disease	0.00288	0.0064	CbGeAlD
Vandetanib—FMO1—digestive system—celiac disease	0.00287	0.00638	CbGeAlD
Vandetanib—IRAK4—lymphoid tissue—celiac disease	0.00286	0.00636	CbGeAlD
Vandetanib—ERBB3—lymphoid tissue—celiac disease	0.0028	0.00623	CbGeAlD
Vandetanib—LYN—liver—celiac disease	0.00279	0.00621	CbGeAlD
Vandetanib—FLT4—blood—celiac disease	0.00277	0.00616	CbGeAlD
Vandetanib—ERBB3—digestive system—celiac disease	0.00277	0.00616	CbGeAlD
Vandetanib—RIPK2—blood—celiac disease	0.00276	0.00613	CbGeAlD
Vandetanib—MAP4K5—pancreas—celiac disease	0.00274	0.00609	CbGeAlD
Vandetanib—TEK—pancreas—celiac disease	0.00274	0.00609	CbGeAlD
Vandetanib—YES1—smooth muscle tissue—celiac disease	0.00274	0.00608	CbGeAlD
Vandetanib—SRC—epithelium—celiac disease	0.00273	0.00607	CbGeAlD
Vandetanib—IRAK4—blood—celiac disease	0.00269	0.00598	CbGeAlD
Vandetanib—KDR—connective tissue—celiac disease	0.00265	0.00589	CbGeAlD
Vandetanib—SRC—smooth muscle tissue—celiac disease	0.00263	0.00585	CbGeAlD
Vandetanib—MKNK1—lymphoid tissue—celiac disease	0.00263	0.00585	CbGeAlD
Vandetanib—MKNK1—digestive system—celiac disease	0.0026	0.00578	CbGeAlD
Vandetanib—FGR—lymphoid tissue—celiac disease	0.0026	0.00578	CbGeAlD
Vandetanib—RET—lymphoid tissue—celiac disease	0.0026	0.00578	CbGeAlD
Vandetanib—AXL—lymphoid tissue—celiac disease	0.00259	0.00576	CbGeAlD
Vandetanib—RET—digestive system—celiac disease	0.00257	0.00571	CbGeAlD
Vandetanib—FGR—digestive system—celiac disease	0.00257	0.00571	CbGeAlD
Vandetanib—YES1—pancreas—celiac disease	0.00253	0.00562	CbGeAlD
Vandetanib—KDR—epithelium—celiac disease	0.00251	0.00559	CbGeAlD
Vandetanib—MKNK1—blood—celiac disease	0.00248	0.00551	CbGeAlD
Vandetanib—FGR—blood—celiac disease	0.00245	0.00544	CbGeAlD
Vandetanib—RET—blood—celiac disease	0.00245	0.00544	CbGeAlD
Vandetanib—LCK—blood—celiac disease	0.00245	0.00544	CbGeAlD
Vandetanib—SRC—pancreas—celiac disease	0.00243	0.00541	CbGeAlD
Vandetanib—FYN—lymphoid tissue—celiac disease	0.00242	0.00539	CbGeAlD
Vandetanib—KDR—smooth muscle tissue—celiac disease	0.00242	0.00538	CbGeAlD
Vandetanib—FYN—digestive system—celiac disease	0.00239	0.00532	CbGeAlD
Vandetanib—FLT3—liver—celiac disease	0.00239	0.0053	CbGeAlD
Vandetanib—MAP4K5—lymphoid tissue—celiac disease	0.00237	0.00527	CbGeAlD
Vandetanib—TEK—lymphoid tissue—celiac disease	0.00237	0.00527	CbGeAlD
Vandetanib—SLK—blood—celiac disease	0.00235	0.00522	CbGeAlD
Vandetanib—STK35—liver—celiac disease	0.00234	0.0052	CbGeAlD
Vandetanib—PDGFRB—connective tissue—celiac disease	0.00229	0.00509	CbGeAlD
Vandetanib—FYN—blood—celiac disease	0.00228	0.00507	CbGeAlD
Vandetanib—ABL2—liver—celiac disease	0.00228	0.00506	CbGeAlD
Vandetanib—MAP4K5—blood—celiac disease	0.00223	0.00496	CbGeAlD
Vandetanib—TEK—blood—celiac disease	0.00223	0.00496	CbGeAlD
Vandetanib—EGFR—liver—celiac disease	0.00222	0.00494	CbGeAlD
Vandetanib—YES1—lymphoid tissue—celiac disease	0.00219	0.00486	CbGeAlD
Vandetanib—PDGFRB—epithelium—celiac disease	0.00217	0.00484	CbGeAlD
Vandetanib—STK10—lymphoid tissue—celiac disease	0.00217	0.00482	CbGeAlD
Vandetanib—FLT4—liver—celiac disease	0.00217	0.00482	CbGeAlD
Vandetanib—YES1—digestive system—celiac disease	0.00216	0.0048	CbGeAlD
Vandetanib—RIPK2—liver—celiac disease	0.00216	0.00479	CbGeAlD
Vandetanib—VEGFA—liver—celiac disease	0.00215	0.00478	CbGeAlD
Vandetanib—STK10—digestive system—celiac disease	0.00214	0.00476	CbGeAlD
Vandetanib—FMO1—liver—celiac disease	0.00214	0.00475	CbGeAlD
Vandetanib—EPHB6—blood—celiac disease	0.00213	0.00474	CbGeAlD
Vandetanib—IRAK4—liver—celiac disease	0.0021	0.00468	CbGeAlD
Vandetanib—SRC—lymphoid tissue—celiac disease	0.0021	0.00468	CbGeAlD
Vandetanib—PDGFRB—smooth muscle tissue—celiac disease	0.0021	0.00466	CbGeAlD
Vandetanib—SRC—digestive system—celiac disease	0.00208	0.00462	CbGeAlD
Vandetanib—ERBB3—liver—celiac disease	0.00206	0.00459	CbGeAlD
Vandetanib—YES1—blood—celiac disease	0.00206	0.00458	CbGeAlD
Vandetanib—ABL1—connective tissue—celiac disease	0.00204	0.00454	CbGeAlD
Vandetanib—STK10—blood—celiac disease	0.00204	0.00453	CbGeAlD
Vandetanib—SRC—blood—celiac disease	0.00198	0.0044	CbGeAlD
Vandetanib—PDGFRB—pancreas—celiac disease	0.00194	0.00431	CbGeAlD
Vandetanib—MKNK1—liver—celiac disease	0.00194	0.00431	CbGeAlD
Vandetanib—KDR—lymphoid tissue—celiac disease	0.00194	0.0043	CbGeAlD
Vandetanib—FGR—liver—celiac disease	0.00191	0.00425	CbGeAlD
Vandetanib—LCK—liver—celiac disease	0.00191	0.00425	CbGeAlD
Vandetanib—KDR—digestive system—celiac disease	0.00191	0.00425	CbGeAlD
Vandetanib—AXL—liver—celiac disease	0.00191	0.00424	CbGeAlD
Vandetanib—ABL1—smooth muscle tissue—celiac disease	0.00187	0.00415	CbGeAlD
Vandetanib—FMO3—liver—celiac disease	0.00185	0.00411	CbGeAlD
Vandetanib—SLK—liver—celiac disease	0.00183	0.00408	CbGeAlD
Vandetanib—MAP2K5—blood—celiac disease	0.00182	0.00405	CbGeAlD
Vandetanib—KDR—blood—celiac disease	0.00182	0.00405	CbGeAlD
Vandetanib—FYN—liver—celiac disease	0.00178	0.00397	CbGeAlD
Vandetanib—TEK—liver—celiac disease	0.00174	0.00387	CbGeAlD
Vandetanib—MAP4K5—liver—celiac disease	0.00174	0.00387	CbGeAlD
Vandetanib—ABL1—pancreas—celiac disease	0.00173	0.00384	CbGeAlD
Vandetanib—PDGFRB—lymphoid tissue—celiac disease	0.00168	0.00372	CbGeAlD
Vandetanib—PDGFRB—digestive system—celiac disease	0.00165	0.00368	CbGeAlD
Vandetanib—YES1—liver—celiac disease	0.00161	0.00358	CbGeAlD
Vandetanib—STK10—liver—celiac disease	0.00159	0.00355	CbGeAlD
Vandetanib—PDGFRB—blood—celiac disease	0.00158	0.00351	CbGeAlD
Vandetanib—SRC—liver—celiac disease	0.00155	0.00344	CbGeAlD
Vandetanib—ABL1—lymphoid tissue—celiac disease	0.00149	0.00332	CbGeAlD
Vandetanib—ORM1—blood—celiac disease	0.00148	0.00329	CbGeAlD
Vandetanib—ABL1—digestive system—celiac disease	0.00147	0.00328	CbGeAlD
Vandetanib—MAP2K5—liver—celiac disease	0.00142	0.00317	CbGeAlD
Vandetanib—KDR—liver—celiac disease	0.00142	0.00317	CbGeAlD
Vandetanib—ABL1—blood—celiac disease	0.00141	0.00312	CbGeAlD
Vandetanib—PDGFRB—liver—celiac disease	0.00123	0.00274	CbGeAlD
Vandetanib—ORM1—liver—celiac disease	0.00116	0.00257	CbGeAlD
Vandetanib—ABL1—liver—celiac disease	0.0011	0.00244	CbGeAlD
Vandetanib—ABCC1—blood—celiac disease	0.00107	0.00238	CbGeAlD
Vandetanib—ALB—liver—celiac disease	0.00101	0.00225	CbGeAlD
Vandetanib—ABCG2—blood—celiac disease	0.000886	0.00197	CbGeAlD
Vandetanib—ABCC1—liver—celiac disease	0.000837	0.00186	CbGeAlD
Vandetanib—ABCG2—liver—celiac disease	0.000693	0.00154	CbGeAlD
Vandetanib—CYP3A4—digestive system—celiac disease	0.000648	0.00144	CbGeAlD
Vandetanib—CYP3A4—blood—celiac disease	0.000617	0.00137	CbGeAlD
Vandetanib—CYP3A4—liver—celiac disease	0.000483	0.00107	CbGeAlD
Vandetanib—LCK—HIV Infection—CD4—celiac disease	9.92e-05	0.00018	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—HLA-DQB1—celiac disease	9.87e-05	0.000179	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CCR4—celiac disease	9.85e-05	0.000179	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CTLA4—celiac disease	9.83e-05	0.000179	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HLA-DQA1—celiac disease	9.78e-05	0.000178	CbGpPWpGaD
Vandetanib—YES1—Immune System—CTLA4—celiac disease	9.75e-05	0.000177	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD79A—celiac disease	9.73e-05	0.000177	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—HLA-DQB1—celiac disease	9.72e-05	0.000177	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—CD8A—celiac disease	9.69e-05	0.000176	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—CD80—celiac disease	9.69e-05	0.000176	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CCR3—celiac disease	9.57e-05	0.000174	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—CD4—celiac disease	9.56e-05	0.000174	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CCR4—celiac disease	9.52e-05	0.000173	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CD8A—celiac disease	9.42e-05	0.000171	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RGS1—celiac disease	9.38e-05	0.00017	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD79A—celiac disease	9.37e-05	0.00017	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—FCGR2A—celiac disease	9.35e-05	0.00017	CbGpPWpGaD
Vandetanib—BLK—Immune System—CD8A—celiac disease	9.32e-05	0.000169	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CCR3—celiac disease	9.32e-05	0.000169	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—SH2B3—celiac disease	9.32e-05	0.000169	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD79A—celiac disease	9.3e-05	0.000169	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—CD80—celiac disease	9.3e-05	0.000169	CbGpPWpGaD
Vandetanib—FGR—Immune System—CD8A—celiac disease	9.29e-05	0.000169	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—CD80—celiac disease	9.25e-05	0.000168	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CCR3—celiac disease	9.22e-05	0.000168	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CD8A—celiac disease	9.22e-05	0.000168	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—CD80—celiac disease	9.19e-05	0.000167	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RGS1—celiac disease	9.18e-05	0.000167	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—TNFAIP3—celiac disease	9.18e-05	0.000167	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-DPB1—celiac disease	9.18e-05	0.000167	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—CD4—celiac disease	9.18e-05	0.000167	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—CD4—celiac disease	9.16e-05	0.000166	CbGpPWpGaD
Vandetanib—LYN—Immune System—FCGR2A—celiac disease	9.15e-05	0.000166	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HLA-DQB1—celiac disease	9.15e-05	0.000166	CbGpPWpGaD
Vandetanib—ABL1—Immune System—FCGR2A—celiac disease	9.11e-05	0.000166	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—SH2B3—celiac disease	9.08e-05	0.000165	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CD8A—celiac disease	9.08e-05	0.000165	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RGS1—celiac disease	9.04e-05	0.000164	CbGpPWpGaD
Vandetanib—FYN—Immune System—FCGR2A—celiac disease	9.01e-05	0.000164	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—SH2B3—celiac disease	8.99e-05	0.000163	CbGpPWpGaD
Vandetanib—LYN—Immune System—TNFAIP3—celiac disease	8.99e-05	0.000163	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HLA-DQA1—celiac disease	8.98e-05	0.000163	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TAGAP—celiac disease	8.97e-05	0.000163	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PTPN2—celiac disease	8.96e-05	0.000163	CbGpPWpGaD
Vandetanib—ABL1—Immune System—TNFAIP3—celiac disease	8.94e-05	0.000163	CbGpPWpGaD
Vandetanib—FYN—Immune System—TNFAIP3—celiac disease	8.85e-05	0.000161	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—CD4—celiac disease	8.83e-05	0.00016	CbGpPWpGaD
Vandetanib—LYN—Immune System—PTPN2—celiac disease	8.78e-05	0.000159	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PTPN2—celiac disease	8.74e-05	0.000159	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—HLA-DRB1—celiac disease	8.73e-05	0.000159	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CTLA4—celiac disease	8.7e-05	0.000158	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—CCR3—celiac disease	8.69e-05	0.000158	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HLA-DQA1—celiac disease	8.65e-05	0.000157	CbGpPWpGaD
Vandetanib—FYN—Immune System—PTPN2—celiac disease	8.64e-05	0.000157	CbGpPWpGaD
Vandetanib—EGFR—Immune System—MBL2—celiac disease	8.61e-05	0.000156	CbGpPWpGaD
Vandetanib—YES1—Immune System—HLA-DQA1—celiac disease	8.59e-05	0.000156	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CD8A—celiac disease	8.54e-05	0.000155	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—SH2B3—celiac disease	8.5e-05	0.000154	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—CD80—celiac disease	8.46e-05	0.000154	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—CD4—celiac disease	8.42e-05	0.000153	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HLA-DQB1—celiac disease	8.4e-05	0.000153	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CCR3—celiac disease	8.38e-05	0.000152	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD79A—celiac disease	8.3e-05	0.000151	CbGpPWpGaD
Vandetanib—LCK—Immune System—MBL2—celiac disease	8.3e-05	0.000151	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—SH2B3—celiac disease	8.17e-05	0.000148	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CCR3—celiac disease	8.09e-05	0.000147	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HLA-DQB1—celiac disease	8.09e-05	0.000147	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—CD4—celiac disease	8.09e-05	0.000147	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—CD80—celiac disease	8.06e-05	0.000146	CbGpPWpGaD
Vandetanib—YES1—Immune System—HLA-DQB1—celiac disease	8.03e-05	0.000146	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—HLA-DRB1—celiac disease	7.89e-05	0.000143	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—SH2B3—celiac disease	7.89e-05	0.000143	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD8A—celiac disease	7.84e-05	0.000142	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DPB1—celiac disease	7.84e-05	0.000142	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RGS1—celiac disease	7.81e-05	0.000142	CbGpPWpGaD
Vandetanib—EGFR—Immune System—FCGR2A—celiac disease	7.79e-05	0.000141	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DPB1—celiac disease	7.67e-05	0.000139	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—HLA-DRB1—celiac disease	7.67e-05	0.000139	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-DQA1—celiac disease	7.66e-05	0.000139	CbGpPWpGaD
Vandetanib—MKNK1—Disease—CD4—celiac disease	7.65e-05	0.000139	CbGpPWpGaD
Vandetanib—EGFR—Immune System—TNFAIP3—celiac disease	7.64e-05	0.000139	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DPB1—celiac disease	7.64e-05	0.000139	CbGpPWpGaD
Vandetanib—BLK—Immune System—HLA-DRB1—celiac disease	7.59e-05	0.000138	CbGpPWpGaD
Vandetanib—FGR—Immune System—HLA-DRB1—celiac disease	7.57e-05	0.000137	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD8A—celiac disease	7.56e-05	0.000137	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DPB1—celiac disease	7.55e-05	0.000137	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RGS1—celiac disease	7.53e-05	0.000137	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—HLA-DRB1—celiac disease	7.51e-05	0.000136	CbGpPWpGaD
Vandetanib—LCK—Immune System—FCGR2A—celiac disease	7.5e-05	0.000136	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD8A—celiac disease	7.5e-05	0.000136	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PTPN2—celiac disease	7.46e-05	0.000136	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CTLA4—celiac disease	7.43e-05	0.000135	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—CD4—celiac disease	7.4e-05	0.000134	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—HLA-DRB1—celiac disease	7.39e-05	0.000134	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—CD80—celiac disease	7.38e-05	0.000134	CbGpPWpGaD
Vandetanib—LCK—Immune System—TNFAIP3—celiac disease	7.36e-05	0.000134	CbGpPWpGaD
Vandetanib—SRC—Immune System—MBL2—celiac disease	7.34e-05	0.000133	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—CD80—celiac disease	7.29e-05	0.000132	CbGpPWpGaD
Vandetanib—LYN—Immune System—CTLA4—celiac disease	7.27e-05	0.000132	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCR4—celiac disease	7.25e-05	0.000132	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CTLA4—celiac disease	7.24e-05	0.000132	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—CD80—celiac disease	7.22e-05	0.000131	CbGpPWpGaD
Vandetanib—LCK—Immune System—PTPN2—celiac disease	7.19e-05	0.000131	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—CD80—celiac disease	7.19e-05	0.000131	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-DQB1—celiac disease	7.16e-05	0.00013	CbGpPWpGaD
Vandetanib—FYN—Immune System—CTLA4—celiac disease	7.16e-05	0.00013	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—CD80—celiac disease	7.11e-05	0.000129	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—CD4—celiac disease	7.1e-05	0.000129	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCR4—celiac disease	7.1e-05	0.000129	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD79A—celiac disease	7.09e-05	0.000129	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CD80—celiac disease	7.08e-05	0.000129	CbGpPWpGaD
Vandetanib—BLK—Immune System—CD80—celiac disease	7.01e-05	0.000127	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—CD80—celiac disease	7.01e-05	0.000127	CbGpPWpGaD
Vandetanib—FGR—Immune System—CD80—celiac disease	6.99e-05	0.000127	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCR4—celiac disease	6.99e-05	0.000127	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HLA-DRB1—celiac disease	6.96e-05	0.000126	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD79A—celiac disease	6.94e-05	0.000126	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CD80—celiac disease	6.94e-05	0.000126	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD79A—celiac disease	6.91e-05	0.000125	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD79A—celiac disease	6.83e-05	0.000124	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CD80—celiac disease	6.83e-05	0.000124	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD8A—celiac disease	6.69e-05	0.000122	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RGS1—celiac disease	6.66e-05	0.000121	CbGpPWpGaD
Vandetanib—SRC—Immune System—FCGR2A—celiac disease	6.64e-05	0.000121	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DQA1—celiac disease	6.54e-05	0.000119	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DPB1—celiac disease	6.52e-05	0.000119	CbGpPWpGaD
Vandetanib—SRC—Immune System—TNFAIP3—celiac disease	6.52e-05	0.000118	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CD80—celiac disease	6.43e-05	0.000117	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DQA1—celiac disease	6.4e-05	0.000116	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HLA-DRB1—celiac disease	6.39e-05	0.000116	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DQA1—celiac disease	6.37e-05	0.000116	CbGpPWpGaD
Vandetanib—SRC—Immune System—PTPN2—celiac disease	6.37e-05	0.000116	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DQA1—celiac disease	6.3e-05	0.000115	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DPB1—celiac disease	6.29e-05	0.000114	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CTLA4—celiac disease	6.19e-05	0.000112	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CCR3—celiac disease	6.16e-05	0.000112	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—CD4—celiac disease	6.15e-05	0.000112	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HLA-DRB1—celiac disease	6.15e-05	0.000112	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—CD80—celiac disease	6.14e-05	0.000112	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DQB1—celiac disease	6.12e-05	0.000111	CbGpPWpGaD
Vandetanib—YES1—Immune System—HLA-DRB1—celiac disease	6.11e-05	0.000111	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCR4—celiac disease	6.04e-05	0.00011	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCR3—celiac disease	6.03e-05	0.00011	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SH2B3—celiac disease	6.01e-05	0.000109	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DQB1—celiac disease	5.99e-05	0.000109	CbGpPWpGaD
Vandetanib—LCK—Immune System—CTLA4—celiac disease	5.96e-05	0.000108	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DQB1—celiac disease	5.96e-05	0.000108	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCR3—celiac disease	5.94e-05	0.000108	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CD80—celiac disease	5.93e-05	0.000108	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—CD80—celiac disease	5.92e-05	0.000108	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD79A—celiac disease	5.9e-05	0.000107	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD80—celiac disease	5.9e-05	0.000107	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DQB1—celiac disease	5.9e-05	0.000107	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SH2B3—celiac disease	5.88e-05	0.000107	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR4—celiac disease	5.82e-05	0.000106	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SH2B3—celiac disease	5.79e-05	0.000105	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD8A—celiac disease	5.71e-05	0.000104	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD79A—celiac disease	5.69e-05	0.000103	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD80—celiac disease	5.69e-05	0.000103	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD80—celiac disease	5.64e-05	0.000103	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—LCT—celiac disease	5.64e-05	0.000102	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—CD4—celiac disease	5.63e-05	0.000102	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD8A—celiac disease	5.59e-05	0.000102	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DPB1—celiac disease	5.57e-05	0.000101	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—CD4—celiac disease	5.57e-05	0.000101	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD8A—celiac disease	5.57e-05	0.000101	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—CD4—celiac disease	5.51e-05	0.0001	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD8A—celiac disease	5.51e-05	0.0001	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—CD4—celiac disease	5.49e-05	9.97e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-DRB1—celiac disease	5.45e-05	9.9e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DQA1—celiac disease	5.45e-05	9.9e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—CD4—celiac disease	5.43e-05	9.87e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CD4—celiac disease	5.41e-05	9.83e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—CD4—celiac disease	5.35e-05	9.73e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—CD4—celiac disease	5.34e-05	9.7e-05	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CD4—celiac disease	5.3e-05	9.62e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CTLA4—celiac disease	5.28e-05	9.59e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DQA1—celiac disease	5.25e-05	9.54e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CD80—celiac disease	5.24e-05	9.52e-05	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CD4—celiac disease	5.21e-05	9.47e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR4—celiac disease	5.15e-05	9.36e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCR3—celiac disease	5.13e-05	9.33e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DQB1—celiac disease	5.09e-05	9.26e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD79A—celiac disease	5.03e-05	9.15e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD80—celiac disease	5.03e-05	9.15e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SH2B3—celiac disease	5e-05	9.09e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCR3—celiac disease	4.95e-05	8.99e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DQB1—celiac disease	4.91e-05	8.92e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CD4—celiac disease	4.91e-05	8.92e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SH2B3—celiac disease	4.82e-05	8.76e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD8A—celiac disease	4.76e-05	8.64e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—CD80—celiac disease	4.71e-05	8.57e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—CD4—celiac disease	4.69e-05	8.52e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DRB1—celiac disease	4.65e-05	8.45e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DQA1—celiac disease	4.65e-05	8.44e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD8A—celiac disease	4.58e-05	8.33e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DRB1—celiac disease	4.55e-05	8.27e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DRB1—celiac disease	4.53e-05	8.24e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CD4—celiac disease	4.53e-05	8.23e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—CD4—celiac disease	4.52e-05	8.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD4—celiac disease	4.5e-05	8.18e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DRB1—celiac disease	4.48e-05	8.15e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR3—celiac disease	4.38e-05	7.96e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DQB1—celiac disease	4.35e-05	7.9e-05	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD4—celiac disease	4.34e-05	7.89e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—CD80—celiac disease	4.31e-05	7.83e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD4—celiac disease	4.31e-05	7.83e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD80—celiac disease	4.3e-05	7.81e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SH2B3—celiac disease	4.27e-05	7.76e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD80—celiac disease	4.21e-05	7.64e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—CD80—celiac disease	4.2e-05	7.63e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD80—celiac disease	4.19e-05	7.61e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—CD80—celiac disease	4.16e-05	7.55e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD80—celiac disease	4.14e-05	7.53e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD8A—celiac disease	4.06e-05	7.37e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CD4—celiac disease	4e-05	7.27e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD80—celiac disease	3.97e-05	7.21e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DRB1—celiac disease	3.87e-05	7.04e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD4—celiac disease	3.84e-05	6.98e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CD80—celiac disease	3.82e-05	6.95e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—CD80—celiac disease	3.78e-05	6.86e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DRB1—celiac disease	3.73e-05	6.78e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—CD80—celiac disease	3.65e-05	6.63e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD80—celiac disease	3.58e-05	6.5e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD80—celiac disease	3.5e-05	6.37e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD80—celiac disease	3.45e-05	6.27e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DRB1—celiac disease	3.3e-05	6e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD80—celiac disease	3.3e-05	6e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD4—celiac disease	3.28e-05	5.96e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD4—celiac disease	3.21e-05	5.84e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD4—celiac disease	3.2e-05	5.81e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD80—celiac disease	3.18e-05	5.79e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD4—celiac disease	3.16e-05	5.75e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD80—celiac disease	3.05e-05	5.55e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD4—celiac disease	3.03e-05	5.5e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CD4—celiac disease	2.92e-05	5.31e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD80—celiac disease	2.82e-05	5.12e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CD80—celiac disease	2.78e-05	5.05e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—celiac disease	2.73e-05	4.96e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CD80—celiac disease	2.72e-05	4.94e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CD80—celiac disease	2.68e-05	4.87e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—celiac disease	2.68e-05	4.86e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—celiac disease	2.63e-05	4.78e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—celiac disease	2.52e-05	4.58e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—celiac disease	2.43e-05	4.42e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—celiac disease	2.33e-05	4.24e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CD80—celiac disease	2.31e-05	4.2e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CD80—celiac disease	2.23e-05	4.05e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—celiac disease	2.15e-05	3.91e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CD80—celiac disease	1.97e-05	3.59e-05	CbGpPWpGaD
